Works matching AU Suo, Shanshan


Results: 15
    1
    2

    Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: A single‐arm, open‐label, phase 2, multicenter study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 10, p. 1579, doi. 10.1002/ajh.27031
    By:
    • Zhang, Yi;
    • Zhang, Qike;
    • Liu, Qingchi;
    • Dang, Huibing;
    • Gao, Sujun;
    • Wang, Wei;
    • Zhou, Hu;
    • Chen, Yuqing;
    • Ma, Liangming;
    • Wang, Jishi;
    • Yang, Haiping;
    • Lu, Binhua;
    • Yin, Hewen;
    • Wu, Liqing;
    • Suo, Shanshan;
    • Zhao, Qingwei;
    • Tong, Hongyan;
    • Jin, Jie
    Publication type:
    Article
    3
    4

    Population Pharmacokinetics‐Pharmacodynamics and Exposure‐Response of Ropeginterferon Alfa‐2b in Chinese and Japanese Patients With Polycythemia Vera.

    Published in:
    Pharmacology Research & Perspectives, 2025, v. 13, n. 3, p. 1, doi. 10.1002/prp2.70109
    By:
    • Qin, Albert;
    • Shimoda, Kazuya;
    • Suo, Shanshan;
    • Fu, Rongfeng;
    • Kirito, Keita;
    • Wu, Daoxiang;
    • Liao, Jason;
    • Chen, Haoqi;
    • Wu, Lei;
    • Su, Xia;
    • Gao, Yucheng;
    • Sato, Toshiaki;
    • Li, Yaning;
    • Zhang, Jingjing;
    • Shen, Weihong;
    • Wang, Wei;
    • Zhang, Lei;
    • Jin, Jie;
    • Komatsu, Norio
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15